Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Follicle Stimulating Hormone Market 2018, Forecast to 2023

Publisher Name :
Date: 14-Aug-2018
No. of pages: 131

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.

Scope of the Report:

This report focuses on the Follicle Stimulating Hormone in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). It is mainly used to treat infertility disease and assisted reproductive technology. At present, this product cannot be replaced in the treatment of infertility.

Currently, There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are top two companies in the world. In 2016, Merck Serono takes about 58.70% of global follicle stimulating hormone revenue. MSD takes about 26.29% of global follicle stimulating hormone revenue.

The worldwide market for Follicle Stimulating Hormone is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Merck Serono

- MSD

- IBSA

- Ferring

- Livzon

- Techwell

- GenSci

- Gedeon Richter

- Teva

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Recombinant FSH

- Urinary FSH

Market Segment by Applications, can be divided into

- Infertility Treatment

- Assisted Reproductive Technology

There are 15 Chapters to deeply display the global Follicle Stimulating Hormone market.

Chapter 1, to describe Follicle Stimulating Hormone Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Follicle Stimulating Hormone, with sales, revenue, and price of Follicle Stimulating Hormone, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Follicle Stimulating Hormone, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Follicle Stimulating Hormone market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Follicle Stimulating Hormone sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Follicle Stimulating Hormone Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Follicle Stimulating Hormone Introduction
1.2 Market Analysis by Type
1.2.1 Recombinant FSH
1.2.2 Urinary FSH
1.3 Market Analysis by Applications
1.3.1 Infertility Treatment
1.3.2 Assisted Reproductive Technology
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck Serono
2.1.1 Business Overview
2.1.1.1 Merck Serono Description
2.1.1.2 Merck Serono Headquarter, Main Business and Finance Overview
2.1.2 Merck Serono Follicle Stimulating Hormone Product Introduction
2.1.2.1 Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
2.1.2.2 Follicle Stimulating Hormone Product Information
2.1.3 Merck Serono Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Merck Serono Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Merck Serono Follicle Stimulating Hormone Market Share in 2017
2.2 MSD
2.2.1 Business Overview
2.2.1.1 MSD Description
2.2.1.2 MSD Headquarter, Main Business and Finance Overview
2.2.2 MSD Follicle Stimulating Hormone Product Introduction
2.2.2.1 Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
2.2.2.2 Follicle Stimulating Hormone Product Information
2.2.3 MSD Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 MSD Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global MSD Follicle Stimulating Hormone Market Share in 2017
2.3 IBSA
2.3.1 Business Overview
2.3.1.1 IBSA Description
2.3.1.2 IBSA Headquarter, Main Business and Finance Overview
2.3.2 IBSA Follicle Stimulating Hormone Product Introduction
2.3.2.1 Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
2.3.2.2 Follicle Stimulating Hormone Product Information
2.3.3 IBSA Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 IBSA Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global IBSA Follicle Stimulating Hormone Market Share in 2017
2.4 Ferring
2.4.1 Business Overview
2.4.1.1 Ferring Description
2.4.1.2 Ferring Headquarter, Main Business and Finance Overview
2.4.2 Ferring Follicle Stimulating Hormone Product Introduction
2.4.2.1 Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
2.4.2.2 Follicle Stimulating Hormone Product Information
2.4.3 Ferring Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Ferring Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Ferring Follicle Stimulating Hormone Market Share in 2017
2.5 Livzon
2.5.1 Business Overview
2.5.1.1 Livzon Description
2.5.1.2 Livzon Headquarter, Main Business and Finance Overview
2.5.2 Livzon Follicle Stimulating Hormone Product Introduction
2.5.2.1 Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
2.5.2.2 Follicle Stimulating Hormone Product Information
2.5.3 Livzon Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Livzon Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Livzon Follicle Stimulating Hormone Market Share in 2017
2.6 Techwell
2.6.1 Business Overview
2.6.1.1 Techwell Description
2.6.1.2 Techwell Headquarter, Main Business and Finance Overview
2.6.2 Techwell Follicle Stimulating Hormone Product Introduction
2.6.2.1 Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
2.6.2.2 Follicle Stimulating Hormone Product Information
2.6.3 Techwell Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Techwell Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Techwell Follicle Stimulating Hormone Market Share in 2017
2.7 GenSci
2.7.1 Business Overview
2.7.1.1 GenSci Description
2.7.1.2 GenSci Headquarter, Main Business and Finance Overview
2.7.2 GenSci Follicle Stimulating Hormone Product Introduction
2.7.2.1 Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
2.7.2.2 Follicle Stimulating Hormone Product Information
2.7.3 GenSci Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 GenSci Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global GenSci Follicle Stimulating Hormone Market Share in 2017
2.8 Gedeon Richter
2.8.1 Business Overview
2.8.1.1 Gedeon Richter Description
2.8.1.2 Gedeon Richter Headquarter, Main Business and Finance Overview
2.8.2 Gedeon Richter Follicle Stimulating Hormone Product Introduction
2.8.2.1 Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
2.8.2.2 Follicle Stimulating Hormone Product Information
2.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Gedeon Richter Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Gedeon Richter Follicle Stimulating Hormone Market Share in 2017
2.9 Teva
2.9.1 Business Overview
2.9.1.1 Teva Description
2.9.1.2 Teva Headquarter, Main Business and Finance Overview
2.9.2 Teva Follicle Stimulating Hormone Product Introduction
2.9.2.1 Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
2.9.2.2 Follicle Stimulating Hormone Product Information
2.9.3 Teva Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Teva Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Teva Follicle Stimulating Hormone Market Share in 2017
3 Global Follicle Stimulating Hormone Market Competition, by Manufacturer
3.1 Global Follicle Stimulating Hormone Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Follicle Stimulating Hormone Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Follicle Stimulating Hormone Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Follicle Stimulating Hormone Manufacturer Market Share in 2017
3.4.2 Top 5 Follicle Stimulating Hormone Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Follicle Stimulating Hormone Market Analysis by Regions
4.1 Global Follicle Stimulating Hormone Sales, Revenue and Market Share by Regions
4.1.1 Global Follicle Stimulating Hormone Sales by Regions (2013-2018)
4.1.2 Global Follicle Stimulating Hormone Revenue by Regions (2013-2018)
4.2 North America Follicle Stimulating Hormone Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Follicle Stimulating Hormone Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Follicle Stimulating Hormone Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Follicle Stimulating Hormone Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Follicle Stimulating Hormone Sales, Revenue and Growth Rate (2013-2018)
5 North America Follicle Stimulating Hormone by Countries, Type, Application and Manufacturers
5.1 North America Follicle Stimulating Hormone Sales, Revenue and Market Share by Countries
5.1.1 North America Follicle Stimulating Hormone Sales by Countries (2013-2018)
5.1.2 North America Follicle Stimulating Hormone Revenue by Countries (2013-2018)
5.1.3 United States Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
5.1.4 Canada Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
5.1.5 Mexico Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
5.2 North America Follicle Stimulating Hormone Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Follicle Stimulating Hormone Sales by Manufacturers (2016-2017)
5.2.2 North America Follicle Stimulating Hormone Revenue by Manufacturers (2016-2017)
5.3 North America Follicle Stimulating Hormone Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Follicle Stimulating Hormone Sales and Sales Share by Type (2013-2018)
5.3.2 North America Follicle Stimulating Hormone Revenue and Revenue Share by Type (2013-2018)
5.4 North America Follicle Stimulating Hormone Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Follicle Stimulating Hormone Sales and Sales Share by Application (2013-2018)
5.4.2 North America Follicle Stimulating Hormone Revenue and Revenue Share by Application (2013-2018)
6 Europe Follicle Stimulating Hormone by Countries, Type, Application and Manufacturers
6.1 Europe Follicle Stimulating Hormone Sales, Revenue and Market Share by Countries
6.1.1 Europe Follicle Stimulating Hormone Sales by Countries (2013-2018)
6.1.2 Europe Follicle Stimulating Hormone Revenue by Countries (2013-2018)
6.1.3 Germany Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
6.1.4 UK Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
6.1.5 France Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
6.1.6 Russia Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
6.1.7 Italy Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
6.2 Europe Follicle Stimulating Hormone Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Follicle Stimulating Hormone Sales by Manufacturers (2016-2017)
6.2.2 Europe Follicle Stimulating Hormone Revenue by Manufacturers (2016-2017)
6.3 Europe Follicle Stimulating Hormone Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Follicle Stimulating Hormone Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Follicle Stimulating Hormone Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Follicle Stimulating Hormone Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Follicle Stimulating Hormone Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Follicle Stimulating Hormone Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Follicle Stimulating Hormone by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Follicle Stimulating Hormone Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Follicle Stimulating Hormone Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Follicle Stimulating Hormone Revenue by Countries (2013-2018)
7.1.3 China Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
7.1.4 Japan Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
7.1.5 Korea Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
7.1.6 India Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Follicle Stimulating Hormone Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Follicle Stimulating Hormone Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Follicle Stimulating Hormone Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Follicle Stimulating Hormone Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Follicle Stimulating Hormone Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Follicle Stimulating Hormone Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Follicle Stimulating Hormone Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Follicle Stimulating Hormone Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Follicle Stimulating Hormone Revenue and Revenue Share by Application (2013-2018)
8 South America Follicle Stimulating Hormone by Countries, Type, Application and Manufacturers
8.1 South America Follicle Stimulating Hormone Sales, Revenue and Market Share by Countries
8.1.1 South America Follicle Stimulating Hormone Sales by Countries (2013-2018)
8.1.2 South America Follicle Stimulating Hormone Revenue by Countries (2013-2018)
8.1.3 Brazil Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
8.1.4 Argentina Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
8.1.5 Colombia Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
8.2 South America Follicle Stimulating Hormone Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Follicle Stimulating Hormone Sales by Manufacturers (2016-2017)
8.2.2 South America Follicle Stimulating Hormone Revenue by Manufacturers (2016-2017)
8.3 South America Follicle Stimulating Hormone Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Follicle Stimulating Hormone Sales and Sales Share by Type (2013-2018)
8.3.2 South America Follicle Stimulating Hormone Revenue and Revenue Share by Type (2013-2018)
8.4 South America Follicle Stimulating Hormone Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Follicle Stimulating Hormone Sales and Sales Share by Application (2013-2018)
8.4.2 South America Follicle Stimulating Hormone Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Follicle Stimulating Hormone by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Follicle Stimulating Hormone Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Follicle Stimulating Hormone Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
9.1.4 UAE Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
9.1.5 Egypt Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
9.1.7 South Africa Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Follicle Stimulating Hormone Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Follicle Stimulating Hormone Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Follicle Stimulating Hormone Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Follicle Stimulating Hormone Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Follicle Stimulating Hormone Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Follicle Stimulating Hormone Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Follicle Stimulating Hormone Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Follicle Stimulating Hormone Revenue and Revenue Share by Application (2013-2018)
10 Global Follicle Stimulating Hormone Market Segment by Type
10.1 Global Follicle Stimulating Hormone Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Follicle Stimulating Hormone Sales and Market Share by Type (2013-2018)
10.1.2 Global Follicle Stimulating Hormone Revenue and Market Share by Type (2013-2018)
10.2 Recombinant FSH Sales Growth and Price
10.2.1 Global Recombinant FSH Sales Growth (2013-2018)
10.2.2 Global Recombinant FSH Price (2013-2018)
10.3 Urinary FSH Sales Growth and Price
10.3.1 Global Urinary FSH Sales Growth (2013-2018)
10.3.2 Global Urinary FSH Price (2013-2018)
11 Global Follicle Stimulating Hormone Market Segment by Application
11.1 Global Follicle Stimulating Hormone Sales Market Share by Application (2013-2018)
11.2 Infertility Treatment Sales Growth (2013-2018)
11.3 Assisted Reproductive Technology Sales Growth (2013-2018)
12 Follicle Stimulating Hormone Market Forecast (2018-2023)
12.1 Global Follicle Stimulating Hormone Sales, Revenue and Growth Rate (2018-2023)
12.2 Follicle Stimulating Hormone Market Forecast by Regions (2018-2023)
12.2.1 North America Follicle Stimulating Hormone Market Forecast (2018-2023)
12.2.2 Europe Follicle Stimulating Hormone Market Forecast (2018-2023)
12.2.3 Asia-Pacific Follicle Stimulating Hormone Market Forecast (2018-2023)
12.2.4 South America Follicle Stimulating Hormone Market Forecast (2018-2023)
12.2.5 Middle East and Africa Follicle Stimulating Hormone Market Forecast (2018-2023)
12.3 Follicle Stimulating Hormone Market Forecast by Type (2018-2023)
12.3.1 Global Follicle Stimulating Hormone Sales Forecast by Type (2018-2023)
12.3.2 Global Follicle Stimulating Hormone Market Share Forecast by Type (2018-2023)
12.4 Follicle Stimulating Hormone Market Forecast by Application (2018-2023)
12.4.1 Global Follicle Stimulating Hormone Sales Forecast by Application (2018-2023)
12.4.2 Global Follicle Stimulating Hormone Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Follicle Stimulating Hormone Picture
Table Product Specifications of Follicle Stimulating Hormone
Figure Global Follicle Stimulating Hormone CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Follicle Stimulating Hormone CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Follicle Stimulating Hormone by Types in 2017
Figure Recombinant FSH Picture
Table Major Manufacturers of Recombinant FSH
Figure Urinary FSH Picture
Table Major Manufacturers of Urinary FSH
Figure Follicle Stimulating Hormone Sales Market Share by Applications in 2017
Figure Infertility Treatment Picture
Figure Assisted Reproductive Technology Picture
Figure United States Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure France Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure UK Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure China Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure India Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2013-2023)
Table Merck Serono Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Serono Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
Table Merck Serono Follicle Stimulating Hormone Product
Table Merck Serono Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Serono Follicle Stimulating Hormone Sales Market Share in 2017
Figure Global Merck Serono Follicle Stimulating Hormone Revenue Market Share in 2017
Table MSD Headquarter, Established, Main Business and Finance Overview (2017)
Table MSD Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
Table MSD Follicle Stimulating Hormone Product
Table MSD Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global MSD Follicle Stimulating Hormone Sales Market Share in 2017
Figure Global MSD Follicle Stimulating Hormone Revenue Market Share in 2017
Table IBSA Headquarter, Established, Main Business and Finance Overview (2017)
Table IBSA Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
Table IBSA Follicle Stimulating Hormone Product
Table IBSA Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global IBSA Follicle Stimulating Hormone Sales Market Share in 2017
Figure Global IBSA Follicle Stimulating Hormone Revenue Market Share in 2017
Table Ferring Headquarter, Established, Main Business and Finance Overview (2017)
Table Ferring Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
Table Ferring Follicle Stimulating Hormone Product
Table Ferring Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ferring Follicle Stimulating Hormone Sales Market Share in 2017
Figure Global Ferring Follicle Stimulating Hormone Revenue Market Share in 2017
Table Livzon Headquarter, Established, Main Business and Finance Overview (2017)
Table Livzon Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
Table Livzon Follicle Stimulating Hormone Product
Table Livzon Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Livzon Follicle Stimulating Hormone Sales Market Share in 2017
Figure Global Livzon Follicle Stimulating Hormone Revenue Market Share in 2017
Table Techwell Headquarter, Established, Main Business and Finance Overview (2017)
Table Techwell Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
Table Techwell Follicle Stimulating Hormone Product
Table Techwell Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Techwell Follicle Stimulating Hormone Sales Market Share in 2017
Figure Global Techwell Follicle Stimulating Hormone Revenue Market Share in 2017
Table GenSci Headquarter, Established, Main Business and Finance Overview (2017)
Table GenSci Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
Table GenSci Follicle Stimulating Hormone Product
Table GenSci Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GenSci Follicle Stimulating Hormone Sales Market Share in 2017
Figure Global GenSci Follicle Stimulating Hormone Revenue Market Share in 2017
Table Gedeon Richter Headquarter, Established, Main Business and Finance Overview (2017)
Table Gedeon Richter Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
Table Gedeon Richter Follicle Stimulating Hormone Product
Table Gedeon Richter Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Gedeon Richter Follicle Stimulating Hormone Sales Market Share in 2017
Figure Global Gedeon Richter Follicle Stimulating Hormone Revenue Market Share in 2017
Table Teva Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Follicle Stimulating Hormone Production Bases, Sales Regions and Major Competitors
Table Teva Follicle Stimulating Hormone Product
Table Teva Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Follicle Stimulating Hormone Sales Market Share in 2017
Figure Global Teva Follicle Stimulating Hormone Revenue Market Share in 2017
Table Global Follicle Stimulating Hormone Sales by Manufacturer (2016-2017)
Figure Global Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2016
Figure Global Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2017
Table Global Follicle Stimulating Hormone Revenue by Manufacturer (2016-2017)
Figure Global Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2016
Figure Global Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2017
Table Global Follicle Stimulating Hormone Price by Manufacturer (2016-2017)
Figure Top 3 Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 2017
Figure Global Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
Figure Global Follicle Stimulating Hormone Revenue and Growth Rate (2013-2018)
Table Global Follicle Stimulating Hormone Sales by Regions (2013-2018)
Table Global Follicle Stimulating Hormone Sales Market Share by Regions (2013-2018)
Table Global Follicle Stimulating Hormone Revenue by Regions (2013-2018)
Figure Global Follicle Stimulating Hormone Revenue Market Share by Regions in 2013
Figure Global Follicle Stimulating Hormone Revenue Market Share by Regions in 2017
Figure North America Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
Figure North America Follicle Stimulating Hormone Revenue and Growth Rate (2013-2018)
Figure Europe Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
Figure Europe Follicle Stimulating Hormone Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Follicle Stimulating Hormone Revenue and Growth Rate (2013-2018)
Figure South America Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
Figure South America Follicle Stimulating Hormone Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Follicle Stimulating Hormone Revenue and Growth Rate (2013-2018)
Figure North America Follicle Stimulating Hormone Revenue and Growth Rate (2013-2018)
Table North America Follicle Stimulating Hormone Sales by Countries (2013-2018)
Table North America Follicle Stimulating Hormone Sales Market Share by Countries (2013-2018)
Figure North America Follicle Stimulating Hormone Sales Market Share by Countries in 2013
Figure North America Follicle Stimulating Hormone Sales Market Share by Countries in 2017
Table North America Follicle Stimulating Hormone Revenue by Countries (2013-2018)
Table North America Follicle Stimulating Hormone Revenue Market Share by Countries (2013-2018)
Figure North America Follicle Stimulating Hormone Revenue Market Share by Countries in 2013
Figure North America Follicle Stimulating Hormone Revenue Market Share by Countries in 2017
Figure United States Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
Figure Canada Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
Figure Mexico Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
Table North America Follicle Stimulating Hormone Sales by Manufacturer (2016-2017)
Figure North America Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2016
Figure North America Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2017
Table North America Follicle Stimulating Hormone Revenue by Manufacturer (2016-2017)
Figure North America Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2016
Figure North America Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2017
Table North America Follicle Stimulating Hormone Sales by Type (2013-2018)
Table North America Follicle Stimulating Hormone Sales Share by Type (2013-2018)
Table North America Follicle Stimulating Hormone Revenue by Type (2013-2018)
Table North America Follicle Stimulating Hormone Revenue Share by Type (2013-2018)
Table North America Follicle Stimulating Hormone Sales by Application (2013-2018)
Table North America Follicle Stimulating Hormone Sales Share by Application (2013-2018)
Table North America Follicle Stimulating Hormone Revenue by Application (2013-2018)
Table North America Follicle Stimulating Hormone Revenue Share by Application (2013-2018)
Figure Europe Follicle Stimulating Hormone Revenue and Growth Rate (2013-2018)
Table Europe Follicle Stimulating Hormone Sales by Countries (2013-2018)
Table Europe Follicle Stimulating Hormone Sales Market Share by Countries (2013-2018)
Table Europe Follicle Stimulating Hormone Revenue by Countries (2013-2018)
Figure Europe Follicle Stimulating Hormone Revenue Market Share by Countries in 2016
Figure Europe Follicle Stimulating Hormone Revenue Market Share by Countries in 2017
Figure Germany Follicle Stimulating Hormone Sales and Growth Rate (2013-2018)
Figure UK Follicle Stim
  • Global Levonorgestrel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantab......
  • Global Equine Pharmaceuticals and Supplements Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 158
    Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases. In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit. Market competition is not intense. Boehringer Ingelheim, Me......
  • Global Cabazitaxel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 132
    Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In......
  • Global Rydapt Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. North America is the largest Sales place, with a Sales market share nearly 75.2% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 24.8%. In USA, The National Cancer Institute estimates that in 2017 approximately 21,380 people will be diagn......
  • Global Hyperimmune Globulins Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 159
    Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccine......
  • Global Transforming Growth Factor Beta 1 Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Transforming growth factor beta 1 or TGF-ß1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-ß1 is encoded by the TGFB1 gene North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is ......
  • Global Traveler's Diarrhea Therapeutics Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week. Traveler's diarrhea is the leading cause of illness among international tra......
  • Global Anticoagulant Drugs Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 31300 million by 2024, from US$ 24600 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anticoag......
  • Global OTC Herbal and Traditional Medicines Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 184
    Herbal medicine--also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease. Herbal medicine industry is dispersive relatively. Currently, th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs